We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Parkinson’s-Fighting Biotech Snags $75M In Series A Funding

Law360 (March 8, 2018, 6:26 PM EST) -- Prevail Therapeutics Inc., a New York biotechnology company focused on fighting neurodegenerative diseases like Parkinson’s, on Thursday said it pocketed $75 million in its latest funding round thanks to investors including...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.